Developers: | Medsintez plant |
Branches: | Pharmaceutics, medicine, health care |
2020: Development of vaccine from all types of a coronavirus
On December 10, 2020 it became known of development in Russia of vaccine against all types of a koronavirusny infection. Medicine which came to a preclinical test phase was created by Medsintez Plant LLC (Novouralsk, Sverdlovsk region).
These are officially preclinical researches on animals, and they are carried out according to rules of proper practice: there is a list that needs to be made, it will be carried out. Yes, [already started preclinical tests]. Month two [it is necessary on tests], I think, in February results will be published — the member of the committee on health protection of the State Duma Alexander Petrov who as he notes news agency before becoming the deputy, was the chairman of the board of directors of Medsintez told TASS. |
According to him, vaccine can be transported and stored at a temperature from +2 to +8 degrees that opens an opportunity to deliver vaccine to the countries of the Middle East from where there is such request and also to the countries of South America. Also Petrov told that vaccine will have a low allergenicity.
The vaccine immunogene causing the immune answer is usually made on the basis of animal protein — chicken or cow protein which happen allergens. As in our medicine they will not be used, I assume that it will be hypoallergenic — he explained. |
Besides, the efficiency of medicine against coronavirus strains is stated, including that which do not exist yet.
It is developed by method of genetic engineering, considers evolutionary process of a virus and will be effective against its versions which will arise — Alexander Petrov told. |
According to him, by December 10, 2020 about 1000 doses of Ural for carrying out tests are made. The expected medicine cost — 1500 rubles.[1]